Region specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Reißmann, Silvana ^a   Gillen, Christine M ^a   Fulde, Marcus ^a   Bergmann, René ^a   Nerlich, Andreas ^a   Rajkumari, Reena ^b   Brahmadathan, Kootallur N ^b   Chhatwal, Gursharan S ^a   Nitsche Schmitz, D Patric ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; COLLAGEN BINDING PROTEIN; M PROTEIN; PARF PROTEIN; PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; COLLAGEN;

ARTICLE; BACTERIUM ISOLATE; BINDING AFFINITY; CONTROLLED STUDY; GEOGRAPHY; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN MOTIF; RHEUMATIC FEVER; RISK FACTOR; STREPTOCOCCUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUISMILIS; STREPTOCOCCUS PYOGENES; SURFACE PLASMON RESONANCE; AMINO ACID SEQUENCE; CHEMISTRY; HUMAN; INDIA; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS PYOGENES;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BACTERIAL PROTEINS; COLLAGEN; GEOGRAPHY; HUMANS; INDIA; INTERNATIONALITY; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; STREPTOCOCCUS PYOGENES;

EID: 84861525993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030122     Document Type: Article

References (48)

1. Cunningham MW, (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511.
2. Efstratiou A, (1997) Pyogenic streptococci of Lancefield groups C and G as pathogens in man. Soc Appl Bacteriol Symp Ser 26: 72S-79S.
3. Baracco GJ, Bisno AL, (2006) Group C and group G streptococcal infections: epidemiologic and clinical aspects. In: Fischetti VA, editors. Gram-positive pathogens. 2nd ed Washington, D.C. ASM Press pp. 223-229.
4. Haidan A, Talay SR, Rohde M, Sriprakash KS, Currie BJ, et al. (2000) Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet 356: 1167-1169.
5. Wannamaker LW, (1973) The chain that links the heart to the throat. Circulation 48: 9-18.
6. Stollerman GH, (1997) Rheumatic fever. Lancet 349: 935-942.
7. Carapetis JR, McDonald M, Wilson NJ, (2005) Acute rheumatic fever. Lancet 366: 155-168.
8. McDonald M, Towers RJ, Andrews RM, Carapetis JR, Currie BJ, (2007) Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in tropical communities, Northern Australia. Emerg Infect Dis 13: 1694-1700.
9. Bisno AL, Craven DE, McCabe WR, (1987) M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun 55: 753-757.
10. Simpson WJ, Robbins JC, Cleary PP, (1987) Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog 3: 339-350.
11. Reissmann S, Friedrichs C, Rajkumari R, Itzek A, Fulde M, et al. (2010) Contribution of Streptococcus anginosus to infections caused by groups C and G streptococci, southern India. Emerg Infect Dis 16: 656-663.
12. Fischetti VA, (1989) Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2: 285-314.
13. Bisno AL, Brito MO, Collins CM, (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3: 191-200.
14. Oehmcke S, Shannon O, Mörgelin M, Herwald H, (2010) Streptococcal M proteins and their role as virulence determinants. Clin Chim Acta 411: 1172-1180.
15. Nitsche-Schmitz DP, Rohde M, Chhatwal GS, (2007) Molecular biology of streptococci: Adhesion and Invasion of Streptococci in Eukaryotic Cells; In: Hakenbeck R, Chhatwal GS, editors. Norwich, U. K. Horizon Bioscience pp. 487-508.
16. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, et al. (1999) emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis 5: 247-253.
17. Cole JN, Henningham A, Gillen CM, Ramachandran V, Walker MJ, (2008) Human pathogenic streptococcal proteomics and vaccine development. Proteomics Clin Appl 2: 387-410.
18. Zaman M, Skwarczynski M, Malcolm JM, Urbani CN, Jia Z, et al. (2010) Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine. Nanomedicine.
19. Kotloff KL, Corretti M, Palmer K, Campbell JD, Reddish MA, et al. (2004) Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial. Jama 292: 709-715.
20. Penfound TA, Chiang EY, Ahmed EA, Dale JB, (2010) Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes. Vaccine 28: 5017-5022.
21. McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, et al. (2005) Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41: 1114-1122.
22. McMillan DJ, Chhatwal GS, (2005) Prospects for a group A streptococcal vaccine. Curr Opin Mol Ther 7: 11-16.
23. Massell BF, Honikman LH, Amezcua J, (1969) Rheumatic fever following streptococcal vaccination. Report of three cases. Jama 207: 1115-1119.
24. Nitsche DP, Johansson HM, Frick IM, Mörgelin M, (2006) Streptococcal protein FOG, a novel matrix adhesin interacting with collagen I in vivo. J Biol Chem 281: 1670-1679.
25. Dinkla K, Rohde M, Jansen WT, Kaplan EL, Chhatwal GS, et al. (2003) Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen. J Clin Invest 111: 1905-1912.
26. Bober M, Enochsson C, Collin M, Mörgelin M, (2010) Collagen VI is a subepithelial adhesive target for human respiratory tract pathogens. J Innate Immun 2: 160-166.
27. Bober M, Mörgelin M, Olin AI, von Pawel-Rammingen U, Collin M, (2011) The membrane bound LRR lipoprotein Slr, and the cell wall-anchored M1 protein from Streptococcus pyogenes both interact with type I collagen. PLoS ONE 6: e20345.
28. Dinkla K, Nitsche-Schmitz DP, Barroso V, Reissmann S, Johansson HM, et al. (2007) Identification of a streptococcal octapeptide motif involved in acute rheumatic fever. J Biol Chem 282: 18686-18693.
29. Barroso V, Rohde M, Davies MR, Gillen CM, Nitsche-Schmitz DP, et al. (2009) Identification of active variants of PARF in human pathogenic group C and group G streptococci leads to an amended description of its consensus motif. Int J Med Microbiol 299: 547-553.
30. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW, (2011) GenBank. Nucleic Acids Res 39: D32-37.
31. Thompson JD, Higgins DG, Gibson TJ, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
32. McDonnell AV, Jiang T, Keating AE, Berger B, (2006) Paircoil2: improved prediction of coiled coils from sequence. Bioinformatics 22: 356-358.
33. Nath LM, Shah B, Prabhakar AK, (1994) Community Control of Rheumatic Fever and Rheumatic Heart Disease New Delhi Indian Council of Medical Research.
34. Kreikemeyer B, Nakata M, Oehmcke S, Gschwendtner C, Normann J, et al. (2005) Streptococcus pyogenes collagen type I-binding Cpa surface protein. Expression profile, binding characteristics, biological functions, and potential clinical impact. J Biol Chem 280: 33228-33239.
35. Kostrzynska M, Schalen C, Wadström T, (1989) Specific binding of collagen type IV to Streptococcus pyogenes. FEMS Microbiol Lett 50: 229-233.
36. Dinkla K, Talay SR, Mörgelin M, Graham RM, Rohde M, et al. (2009) Crucial role of the CB3-region of collagen IV in PARF-induced acute rheumatic fever. PLoS ONE 4: e4666.
37. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR, (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9: 611-616.
38. Phillips GN Jr, Flicker PF, Cohen C, Manjula BN, Fischetti VA, (1981) Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A 78: 4689-4693.
39. McNamara C, Zinkernagel AS, Macheboeuf P, Cunningham MW, Nizet V, et al. (2008) Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science 319: 1405-1408.
40. Nilson BH, Frick IM, Akesson P, Forsen S, Björck L, et al. (1995) Structure and stability of protein H and the M1 protein from Streptococcus pyogenes. Implications for other surface proteins of gram-positive bacteria. Biochemistry 34: 13688-13698.
41. Cedervall T, Johansson MU, Akerström B, (1997) Coiled-coil structure of group A streptococcal M proteins. Different temperature stability of class A and C proteins by hydrophobic-nonhydrophobic amino acid substitutions at heptad positions a and d. Biochemistry 36: 4987-4994.
42. Ma Y, Yang Y, Huang M, Wang Y, Chen Y, et al. (2009) Characterization of emm types and superantigens of Streptococcus pyogenes isolates from children during two sampling periods. Epidemiol Infect 137: 1414-1419.
43. Tseng SP, Lin YY, Tsai JC, Hsueh PR, Chen HJ, et al. (2010) Distribution of emm types and genetic characterization of the mgc locus in group G Streptococcus dysgalactiae subsp. equisimilis from a hospital in northern Taiwan. J Clin Microbiol 48: 2975-2977.
44. Kittang BR, Langeland N, Mylvaganam H, (2008) Distribution of emm types and subtypes among noninvasive group A, C and G streptococcal isolates in western Norway. APMIS 116: 457-464.
45. Pinho MD, Melo-Cristino J, Ramirez M, (2006) Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness. J Clin Microbiol 44: 841-846.
46. Sunaoshi K, Murayama SY, Adachi K, Yagoshi M, Okuzumi K, et al. (2010) Molecular emm genotyping and antibiotic susceptibility of Streptococcus dysgalactiae subsp. equisimilis isolated from invasive and non-invasive infections. J Med Microbiol 59: 82-88.
47. Bramhachari PV, Kaul SY, McMillan DJ, Shaila MS, Karmarkar MG, et al. (2010) Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children. J Med Microbiol 59: 220-223.
48. Dale JB, Penfound TA, Chiang EY, Walton WJ, (2011) New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine 29: 8175-8178.